Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants
A Single-dose, Phase 1, Open-label Study to Evaluate the Mass Balance and Absorption, Distribution, Metabolism, and Excretion of [14C]Xeruborbactam (QPX7728) Following Administration of a Solution for Intravenous Infusion in Healthy Adult Male Participants
Sponsor: Qpex Biopharma, Inc.
A PHASE1 clinical study on ADME, this trial is completed. The trial is conducted by Qpex Biopharma, Inc. and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
Status: Not Yet Recruiting → Completed
-
Aug 2025 — Sep 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Qpex Biopharma, Inc.
- Shionogi Inc.
For direct contact, visit the study record on ClinicalTrials.gov .